Seattle Childrens Hospital Dialysis is a medicare approved dialysis facility center in Seattle, Washington and it has 7 dialysis stations. It is located in King county at 4800 Sand Point Way Ne Oc.9.820, Seattle, WA, 98105. You can reach out to the office of Seattle Childrens Hospital Dialysis at (206) 987-3985. This dialysis clinic is run as an Independent entity i.e it is not owned by any chain organization. Seattle Childrens Hospital Dialysis has the following ownership type - Non-Profit. It was first certified by medicare in September, 1977. The medicare id for this facility is 503300 and it accepts patients under medicare ESRD program.
Name | Seattle Childrens Hospital Dialysis |
---|---|
Location | 4800 Sand Point Way Ne Oc.9.820, Seattle, Washington |
No. of Dialysis Stations | 7 |
Medicare ID | 503300 |
Managed By | Independent |
Ownership Type | Non-Profit |
Late Shifts | No |
4800 Sand Point Way Ne Oc.9.820, Seattle, Washington, 98105 | |
(206) 987-3985 | |
Not Available |
News Archive
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX in the U.S. and XIAPEX in Europe and Eurasia, today announced that The Journal of Urology has electronically published the uncorrected proof of the pivotal IMPRESS (The Investigation for Maximal Peyronie's Reduction Efficacy and Safety Studies) trials on its website.
A disturbing new trend in suicide pacts involving strangers meeting over the internet (cybersuicide) is emerging, warns a consultant psychiatrist in this week's BMJ.
The Associated Press: The Senate opened debate Monday on landmark health care legislation that would extend coverage to millions of uninsured and ban onerous insurance practices, with Democrats vowing to work weekends to deliver on President Barack Obama's domestic initiative by year's end.
COVID-19 has placed tremendous pressure on health care systems, not only for critical care but also from an anxious public looking for answers.
› Verified 9 days ago
Dialysis patients with Hemoglobin data | 25 |
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 12 |
Medicare patients who had average hemoglobin (hgb) greater than 12 g/dL | 12 |
News Archive
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX in the U.S. and XIAPEX in Europe and Eurasia, today announced that The Journal of Urology has electronically published the uncorrected proof of the pivotal IMPRESS (The Investigation for Maximal Peyronie's Reduction Efficacy and Safety Studies) trials on its website.
A disturbing new trend in suicide pacts involving strangers meeting over the internet (cybersuicide) is emerging, warns a consultant psychiatrist in this week's BMJ.
The Associated Press: The Senate opened debate Monday on landmark health care legislation that would extend coverage to millions of uninsured and ban onerous insurance practices, with Democrats vowing to work weekends to deliver on President Barack Obama's domestic initiative by year's end.
COVID-19 has placed tremendous pressure on health care systems, not only for critical care but also from an anxious public looking for answers.
› Verified 9 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
Adult patients getting regular hemodialysis at the center | 3 |
Adult patient months included in Kt/V greater than or equal to 1.2 | 22 |
Percentage of adult patients getting regular hemodialysis at the center | |
Pediatic patients getting regular hemodialysis at the center | 7 |
Pediatric patient months included in in Kt/V greater than or eqaul to 1.2 | 34 |
Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX in the U.S. and XIAPEX in Europe and Eurasia, today announced that The Journal of Urology has electronically published the uncorrected proof of the pivotal IMPRESS (The Investigation for Maximal Peyronie's Reduction Efficacy and Safety Studies) trials on its website.
A disturbing new trend in suicide pacts involving strangers meeting over the internet (cybersuicide) is emerging, warns a consultant psychiatrist in this week's BMJ.
The Associated Press: The Senate opened debate Monday on landmark health care legislation that would extend coverage to millions of uninsured and ban onerous insurance practices, with Democrats vowing to work weekends to deliver on President Barack Obama's domestic initiative by year's end.
COVID-19 has placed tremendous pressure on health care systems, not only for critical care but also from an anxious public looking for answers.
› Verified 9 days ago
Adult patients getting regular peritoneal dialysis at the center | 4 |
Adult patient months included in Kt/V greater than or equal to 1.7 | 12 |
Percentage of adult patients getting regular peritoneal dialysis at the center | |
Pediatric patients getting regular peritoneal dialysis at the centre | 23 |
Pediatric patient months included in Kt/V greater than or equal to 1.7 | 145 |
Percentage of pediatric patients getting regular peritoneal dialysis at the center | 79 |
News Archive
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX in the U.S. and XIAPEX in Europe and Eurasia, today announced that The Journal of Urology has electronically published the uncorrected proof of the pivotal IMPRESS (The Investigation for Maximal Peyronie's Reduction Efficacy and Safety Studies) trials on its website.
A disturbing new trend in suicide pacts involving strangers meeting over the internet (cybersuicide) is emerging, warns a consultant psychiatrist in this week's BMJ.
The Associated Press: The Senate opened debate Monday on landmark health care legislation that would extend coverage to millions of uninsured and ban onerous insurance practices, with Democrats vowing to work weekends to deliver on President Barack Obama's domestic initiative by year's end.
COVID-19 has placed tremendous pressure on health care systems, not only for critical care but also from an anxious public looking for answers.
› Verified 9 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Seattle Childrens Hospital Dialysis with elevated calcium levels.
Patients with hypercalcemia | 8 |
Hypercalcemia patient months | 60 |
Hypercalcemia patients with serumcalcium greater than 10.2 mg | |
Patients with Serumphosphor | 7 |
Patients with Serumphosphor less than 3.5 mg/dL | |
Patients with Serumphosphor from 3.5 to 4.5 mg/dL | |
Patients with Serumphosphor from 4.6 to 5.5 mg/dL | |
Patients with Serumphosphor from 5.6 to 7 mg/dL | |
Patients with Serumphosphor greater than 7 mg/dL |
News Archive
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX in the U.S. and XIAPEX in Europe and Eurasia, today announced that The Journal of Urology has electronically published the uncorrected proof of the pivotal IMPRESS (The Investigation for Maximal Peyronie's Reduction Efficacy and Safety Studies) trials on its website.
A disturbing new trend in suicide pacts involving strangers meeting over the internet (cybersuicide) is emerging, warns a consultant psychiatrist in this week's BMJ.
The Associated Press: The Senate opened debate Monday on landmark health care legislation that would extend coverage to millions of uninsured and ban onerous insurance practices, with Democrats vowing to work weekends to deliver on President Barack Obama's domestic initiative by year's end.
COVID-19 has placed tremendous pressure on health care systems, not only for critical care but also from an anxious public looking for answers.
› Verified 9 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
Patients included in arterial venous fistula and catheter summaries | 4 |
Patient months included in arterial venous fistula and catheter summaries | 28 |
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | |
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer |
News Archive
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX in the U.S. and XIAPEX in Europe and Eurasia, today announced that The Journal of Urology has electronically published the uncorrected proof of the pivotal IMPRESS (The Investigation for Maximal Peyronie's Reduction Efficacy and Safety Studies) trials on its website.
A disturbing new trend in suicide pacts involving strangers meeting over the internet (cybersuicide) is emerging, warns a consultant psychiatrist in this week's BMJ.
The Associated Press: The Senate opened debate Monday on landmark health care legislation that would extend coverage to millions of uninsured and ban onerous insurance practices, with Democrats vowing to work weekends to deliver on President Barack Obama's domestic initiative by year's end.
COVID-19 has placed tremendous pressure on health care systems, not only for critical care but also from an anxious public looking for answers.
› Verified 9 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
Patients in facility's Hospitalization Summary | 34 |
Hospitalization Rate in facility | 183.8 (As Expected) |
Hospitalization Rate: Upper Confidence Limit | 344.6 |
Hospitalization Rate: Lower Confidence Limit | 103 |
News Archive
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX in the U.S. and XIAPEX in Europe and Eurasia, today announced that The Journal of Urology has electronically published the uncorrected proof of the pivotal IMPRESS (The Investigation for Maximal Peyronie's Reduction Efficacy and Safety Studies) trials on its website.
A disturbing new trend in suicide pacts involving strangers meeting over the internet (cybersuicide) is emerging, warns a consultant psychiatrist in this week's BMJ.
The Associated Press: The Senate opened debate Monday on landmark health care legislation that would extend coverage to millions of uninsured and ban onerous insurance practices, with Democrats vowing to work weekends to deliver on President Barack Obama's domestic initiative by year's end.
COVID-19 has placed tremendous pressure on health care systems, not only for critical care but also from an anxious public looking for answers.
› Verified 9 days ago
The rate of readmission show you whether patients who were being treated regularly at Seattle Childrens Hospital Dialysis were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
Readmission Rate in facility | 14.7 (As Expected) |
Readmission Rate: Upper Confidence Limit | 24.5 |
Readmission Rate: Lower Confidence Limit | 7.4 |
News Archive
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX in the U.S. and XIAPEX in Europe and Eurasia, today announced that The Journal of Urology has electronically published the uncorrected proof of the pivotal IMPRESS (The Investigation for Maximal Peyronie's Reduction Efficacy and Safety Studies) trials on its website.
A disturbing new trend in suicide pacts involving strangers meeting over the internet (cybersuicide) is emerging, warns a consultant psychiatrist in this week's BMJ.
The Associated Press: The Senate opened debate Monday on landmark health care legislation that would extend coverage to millions of uninsured and ban onerous insurance practices, with Democrats vowing to work weekends to deliver on President Barack Obama's domestic initiative by year's end.
COVID-19 has placed tremendous pressure on health care systems, not only for critical care but also from an anxious public looking for answers.
› Verified 9 days ago